Labenz and Schoppmann discuss the approach to treatment for patients with gastro-esophageal reflux disease that is resistant to standard medical treatment with proton pump inhibitors. They highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback